Quiflor 20 mg/ml Solution for Injection for Cattle, Pigs and Dogs

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

지금 구매하세요

Download 제품 특성 요약 (SPC)
23-05-2022

유효 성분:

Marbofloxacin

제공처:

Krka d.d., Novo Mesto

ATC 코드:

QJ01MA93

INN (국제 이름):

Marbofloxacin

약제 형태:

Solution for injection

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Cattle, Dogs, Pigs

치료 영역:

Antimicrobial

승인 상태:

Expired

승인 날짜:

2011-12-19

제품 특성 요약

                                Revised: June 2016
AN: 00896/2015
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Quiflor 20 mg/ml solution for injection for cattle, pigs and dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml of solution for injection contains:
ACTIVE SUBSTANCE:
Marbofloxacin
20 mg
EXCIPIENTS:
Metacresol
2 mg
Disodium edetate
0.10 mg
Monothioglycerol
0.50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, greenish yellow to brownish yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (pre-ruminant calves up to 100 kg b.w).
Pigs.
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATTLE (PRE-RUMINANT CALVES UP TO 100 KG B.W)
Treatment of respiratory infections caused by sensitive strains of
_Mannheimia _
_haemolytica, Pasteurella multocida, _and_ Mycoplasma bovis._
FATTENING PIGS
Treatment of respiratory infections caused by sensitive strains of
_Actinobacillus _
_pleuropneumoniae, Pasteurella multocida _and _Mycoplasma
hyopneumoniae,._
DOGS
Revised: June 2016
AN: 00896/2015
Page 2 of 7
Treatment of infected wounds (including drained subcutaneous
abscesses)_ _due to
_Escherichia coli_, _Pasteurella _sp. and _Pseudomonas _sp.
Treatment of lower or urinary tract infections due to _Escherichia
coli and Proteus _sp.
The veterinary medicinal product should only be used based on
susceptibility testing.
4.3
CONTRAINDICATIONS
Do not administer in animals with known hypersensitivity to
marbofloxacin or any
other quinolone or to any of the excipients.
Marbofloxacin should not be used in dogs aged less than 12 months or
less than 18
months for exceptionally large breeds of dogs, such as Great Danes or
mastiffs with
a longer growth period.
Do not use in cases where the pathogen involved is resistant to other
fluoroquinolones (cross resistance).
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low urinary pH could have an inhibitory effect on the activity of
marbofloxacin.
4.5
SPECIAL PRECAUTIONS FOR USE
Special pre
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림